JAMES WIADUCK: Open Payments
NPI 1114946506 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,331 in 25 payments from 11 companies in 2025. Trend: 2023 $1,007 · 2024 $895 · 2025 $1,331
Food & beverage: $1,331
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $294 |
| Janssen Pharmaceuticals, Inc | 3 | $208 |
| Alkermes, Inc. | 4 | $172 |
| E.R. Squibb & Sons, L.L.C. | 3 | $159 |
| Neurocrine BioSciences, Inc. | 1 | $138 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Lundbeck LLC | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, COBENFY, INGREZZA, VRAYLAR, CAPLYTA, LYBALVI, ARISTADA.
Industry payments across MI — which companies pay providers there.
